The Aurum Institute Npc
Clinical trials sponsored by The Aurum Institute Npc, explained in plain language.
-
New study aims to safely prevent TB in pregnant moms with HIV
Disease control OngoingThis study looks at two short courses of medicine to prevent tuberculosis (TB) in pregnant women who also have HIV. About 252 pregnant women will take either a daily pill for one month or a weekly pill for three months. Researchers will check if these treatments are safe and how …
Phase: PHASE1, PHASE2 • Sponsor: The Aurum Institute NPC • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New hope: short TB prevention for kids with HIV
Disease control OngoingThis study tests a once-weekly, 12-dose treatment for latent tuberculosis (TB) in children and teens with HIV. The goal is to see if it is safe and how it interacts with their HIV medication dolutegravir. About 92 participants aged 3 months to 17 years will be enrolled.
Phase: PHASE1, PHASE2 • Sponsor: The Aurum Institute NPC • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
One-Month TB prevention pill could beat Three-Month regimen in High-Risk groups
Prevention OngoingThis study tests if a one-month daily TB prevention treatment works as well as a three-month weekly one in people with HIV and in HIV-negative household contacts of TB patients. The goal is to see which approach leads to better treatment completion and fewer side effects. About 1…
Phase: PHASE4 • Sponsor: The Aurum Institute NPC • Aim: Prevention
Last updated May 26, 2026 11:24 UTC